254 related articles for article (PubMed ID: 26402008)
1. Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk.
Leifert WR; Nguyen T; Rembach A; Martins R; Rainey-Smith S; Masters CL; Ames D; Rowe CC; Macaulay SL; François M; Fenech MF;
J Alzheimers Dis; 2015; 48(2):443-52. PubMed ID: 26402008
[TBL] [Abstract][Full Text] [Related]
2. Buccal cell cytokeratin 14 identifies mild cognitive impairment and Alzheimer' s disease in the AIBL study of aging.
Leifert WR; Tuli JF; Francois M; Nguyen T; Rembach A; Rumble RL; Rainey-Smith S; Martins R; Fenech MF
Curr Alzheimer Res; 2015; 12(3):233-41. PubMed ID: 25731627
[TBL] [Abstract][Full Text] [Related]
3. Altered cytological parameters in buccal cells from individuals with mild cognitive impairment and Alzheimer's disease.
François M; Leifert W; Hecker J; Faunt J; Martins R; Thomas P; Fenech M
Cytometry A; 2014 Aug; 85(8):698-708. PubMed ID: 24616437
[TBL] [Abstract][Full Text] [Related]
4. Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle study.
Faux NG; Ellis KA; Porter L; Fowler CJ; Laws SM; Martins RN; Pertile KK; Rembach A; Rowe CC; Rumble RL; Szoeke C; Taddei K; Taddei T; Trounson BO; Villemagne VL; Ward V; Ames D; Masters CL; Bush AI
J Alzheimers Dis; 2011; 27(4):909-22. PubMed ID: 21891867
[TBL] [Abstract][Full Text] [Related]
5. Plasma Homocysteine and Serum Folate and Vitamin B
Ma F; Wu T; Zhao J; Ji L; Song A; Zhang M; Huang G
Nutrients; 2017 Jul; 9(7):. PubMed ID: 28698453
[TBL] [Abstract][Full Text] [Related]
6. Buccal Cytome Biomarkers and Their Association with Plasma Folate, Vitamin B12 and Homocysteine in Alzheimer's Disease.
Thomas P; Fenech M
J Nutrigenet Nutrigenomics; 2015; 8(2):57-69. PubMed ID: 26228832
[TBL] [Abstract][Full Text] [Related]
7. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
8. Plasma protein profiling of mild cognitive impairment and Alzheimer's disease across two independent cohorts.
Muenchhoff J; Poljak A; Song F; Raftery M; Brodaty H; Duncan M; McEvoy M; Attia J; Schofield PW; Sachdev PS
J Alzheimers Dis; 2015; 43(4):1355-73. PubMed ID: 25159666
[TBL] [Abstract][Full Text] [Related]
9. High Content, Multi-Parameter Analyses in Buccal Cells to Identify Alzheimer's Disease.
François M; Fenech MF; Thomas P; Hor M; Rembach A; Martins RN; Rainey-Smith SR; Masters CL; Ames D; Rowe CC; Macaulay SL; Hill AF; Leifert WR; The Australian Imaging Biomarkers And Lifestyle Study Research Group
Curr Alzheimer Res; 2016; 13(7):787-99. PubMed ID: 26975368
[TBL] [Abstract][Full Text] [Related]
10. Rates of diagnostic transition and cognitive change at 18-month follow-up among 1,112 participants in the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing (AIBL).
Ellis KA; Szoeke C; Bush AI; Darby D; Graham PL; Lautenschlager NT; Macaulay SL; Martins RN; Maruff P; Masters CL; McBride SJ; Pike KE; Rainey-Smith SR; Rembach A; Robertson J; Rowe CC; Savage G; Villemagne VL; Woodward M; Wilson W; Zhang P; Ames D;
Int Psychogeriatr; 2014 Apr; 26(4):543-54. PubMed ID: 24252258
[TBL] [Abstract][Full Text] [Related]
11. Conversion from cognitive health to mild cognitive impairment and Alzheimer's disease: prediction by plasma amyloid beta 42, medial temporal lobe atrophy and homocysteine.
Blasko I; Jellinger K; Kemmler G; Krampla W; Jungwirth S; Wichart I; Tragl KH; Fischer P
Neurobiol Aging; 2008 Jan; 29(1):1-11. PubMed ID: 17055615
[TBL] [Abstract][Full Text] [Related]
12. Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease.
Torres LL; Quaglio NB; de Souza GT; Garcia RT; Dati LM; Moreira WL; Loureiro AP; de Souza-Talarico JN; Smid J; Porto CS; Bottino CM; Nitrini R; Barros SB; Camarini R; Marcourakis T
J Alzheimers Dis; 2011; 26(1):59-68. PubMed ID: 21593563
[TBL] [Abstract][Full Text] [Related]
13. Relationship of cognitive function with B vitamin status, homocysteine, and tissue factor pathway inhibitor in cognitively impaired elderly: a cross-sectional survey.
Kim G; Kim H; Kim KN; Son JI; Kim SY; Tamura T; Chang N
J Alzheimers Dis; 2013; 33(3):853-62. PubMed ID: 23042212
[TBL] [Abstract][Full Text] [Related]
14. The relationship of plasma Aβ levels to dementia in aging individuals with mild cognitive impairment.
Fei M; Jianghua W; Rujuan M; Wei Z; Qian W
J Neurol Sci; 2011 Jun; 305(1-2):92-6. PubMed ID: 21440911
[TBL] [Abstract][Full Text] [Related]
15. γH2AX is increased in peripheral blood lymphocytes of Alzheimer's disease patients in the South Australian Neurodegeneration, Nutrition and DNA Damage (SAND) study of aging.
Siddiqui MS; Francois M; Hecker J; Faunt J; Fenech MF; Leifert WR
Mutat Res Genet Toxicol Environ Mutagen; 2018; 829-830():6-18. PubMed ID: 29704994
[TBL] [Abstract][Full Text] [Related]
16. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
[TBL] [Abstract][Full Text] [Related]
17. Serum vitamin D in patients with mild cognitive impairment and Alzheimer's disease.
Ouma S; Suenaga M; Bölükbaşı Hatip FF; Hatip-Al-Khatib I; Tsuboi Y; Matsunaga Y
Brain Behav; 2018 Mar; 8(3):e00936. PubMed ID: 29541546
[TBL] [Abstract][Full Text] [Related]
18. Lymphocytic mitochondrial aconitase activity is reduced in Alzheimer's disease and mild cognitive impairment.
Mangialasche F; Baglioni M; Cecchetti R; Kivipelto M; Ruggiero C; Piobbico D; Kussmaul L; Monastero R; Brancorsini S; Mecocci P
J Alzheimers Dis; 2015; 44(2):649-60. PubMed ID: 25322927
[TBL] [Abstract][Full Text] [Related]
19. Reduced TRPC6 mRNA levels in the blood cells of patients with Alzheimer's disease and mild cognitive impairment.
Lu R; Wang J; Tao R; Wang J; Zhu T; Guo W; Sun Y; Li H; Gao Y; Zhang W; Fowler CJ; Li Q; Chen S; Wu Z; Masters CL; Zhong C; Jing N; Wang Y; Wang Y
Mol Psychiatry; 2018 Mar; 23(3):767-776. PubMed ID: 28696436
[TBL] [Abstract][Full Text] [Related]
20. Lead and manganese levels in serum and erythrocytes in Alzheimer's disease and mild cognitive impairment: results from the Australian Imaging, Biomarkers and Lifestyle Flagship Study of Ageing.
Hare DJ; Faux NG; Roberts BR; Volitakis I; Martins RN; Bush AI
Metallomics; 2016 Jun; 8(6):628-32. PubMed ID: 26962965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
